Key result
Growth hormone replacement linked to reduced vagally mediated HRV in children with GH deficiency.
Why the study?
Growth hormone exerts cardiovascular effects, but its impact on cardiac autonomic functions in children was unknown.
Does growth hormone replacement treatment alter heart rate variability in pediatric patients with isolated growth hormone deficiency?
Observational (n=10)
Does growth hormone replacement treatment alter heart rate variability in pediatric patients with isolated growth hormone deficiency?
Growth hormone replacement therapy in children with isolated GH deficiency significantly reduces vagally mediated HRV parameters after 6 months, indicating early effects on autonomic regulation.
Answers are grounded in this paper and cite their sources.
Childhood GHRT effects on HRV parameters need prospective validation; leaves open implications for adult autonomic or cardiovascular risk.
Purpose Growth hormone (GH), which has been used for many years for various indications, has been extensively studied because of its systemic effects. One notable effect is on the cardiovascular system. Heart rate variability (HRV) is a widely used noninvasive tool for understanding environmental factors, diseases, and treatment effects, providing insights into the autonomic nervous system (ANS). This study aimed to examine the effects of childhood GH replacement treatment (GHRT) on HRV parameters and their implications for the ANS. Methods The study included 10 pediatric patients (mean age 12.01 ± 1.38 years) evaluated for short stature and diagnosed with isolated GH deficiency (GHD). Time‐domain parameters of HRV were examined in patients with a 24 h Holter monitoring before GHRT and after six months of treatment. Results Root mean square of the successive normal sinus R–R interval difference (RMSSD) and percentage of successive normal sinus R–R intervals longer than 50 milliseconds (pNN50), which are known to correlate with the parasympathetic nervous system, decreased significantly after 6 months of treatment compared to baseline. No significant changes were observed in the other time‐domain parameters, the standard deviation of all normal sinus R–R intervals (SDNN), and the standard deviation of the averages of R–R intervals in all 5 min segments of the recording (SDANN). Conclusion GHRT in childhood was associated with significant reductions in vagally mediated HRV parameters, suggesting an effect on autonomic regulation during the early phase of treatment. Long‐term studies are required to determine whether these changes persist or normalize over time. This appears to be the first study to investigate the effects of GHRT on ANS function in children with GHD.
No takes yet. Share an insight, caveat, or question.
Sel et al. (2026) conducted an observational in Isolated GH deficiency (GHD) (n=10). Growth hormone replacement treatment (GHRT) vs. Baseline (before treatment) was evaluated on Time-domain parameters of heart rate variability (HRV). Growth hormone replacement treatment in children with isolated GH deficiency significantly reduced vagally mediated HRV parameters (RMSSD and pNN50) after 6 months compared to baseline.
Synapse has enriched 10 related papers. Consider them for comparative context: